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A relationship between central venous catheter (CVC) tip colonisation and catheter-related blood-stream infection (CRBSI) has
been suggested. We examined culture positivity of CVC tips (colonised and infected CVCs) in a total parenteral nutrition (TPN)
population. Our aims were to define the relationship between culture positivity and CRBSI, and to compare causative organisms
between culture positive and CRBSI CVCS, and between ward and ICU CVCs. All patients receiving TPN via non-tunnelled CVCs
during the study (1997–2009) were included. All CVC tips were analysed. Data were collated contemporaneously. A TPN audit
committee determined whether CVC tip culture positivity reflected colonisation/CRBSI using CDC criteria. 1,392 patients received
TPN via 2,565 CVCs over 15,397 CVC days. 25.4% of CVCs tips were culture positive, of these 32% developed CRBSI. There was
a nonsignificant trend of higher Gram negative Bacilli isolation in ICU CVCs (P = 0.1), ward CVCs were associated with higher
rates of staphylococcal isolation (P = 0.01). A similar pattern of organisms were cultured from CRBSI and culture positive CVCs.
The consistent relationship between CRBSI and culture positive CVCs, and similar pattern of causative organisms further supports
an aetiological relationship between culture positive CVC tips and CRBSI, supporting the contention that CVC culture-positivity
may be a useful surrogate marker for CRBSI rates.
1. Introduction
Septic complications of central venous catheters (CVCs)
remain a significant cause of patient morbidity andmortality
both in the intensive care unit (ICU) and on general hospital
wards. Approximately 25% of CVCs inserted have been
reported to become colonised [1], with rates of catheter-
related blood stream infection (CRBSI) varying between 0%
and 11% [2–8]. On the basis of varied items of data [1, 9, 10],
there is preliminary evidence that colonisation of CVCs may
play a role as a pathogenic mechanism for the development
of CRBSI.
There is limited data on CVC colonisation and CRBSI
rates outside the ICU, in part due to the perceived high
usage of CVCs within the ICU setting. However, because of
the larger population of patients managed at ward level, the
majority of CVCs may in fact be inserted and maintained
in patients located outside of the ICU on general wards, as
high as 70% in one survey [11]. This suggests that hospital
wide surveillance of CVC complications should be a priority
and focus is now turning toward the measurement of CRBSI
incidence and epidemiology in CVCs inserted in patients
at ward level [12]. It has also been contended, but with
limited evidential support [13–15], that CVCs inserted in
ICU patients may have diﬀerent incidence of infectious com-
plications relative to CVCs inserted in ward patients, with
diﬀerent patterns of causative organisms. This has obvious
implications for best CVC insertion practice and empiric
antimicrobial therapy in the event of CVC-related sepsis.
The aims of this 12-year study were to document the
proportion of CVCs in a hospital-wide TPN population
that became tip culture positive (incorporating colonised
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and infected CVCs), and to examine the consistency of
any relationship between culture positivity of CVC tips
and development of CRBSI. We also aimed to define the
microbiological pattern of causative organisms of culture
positive and CRBSI CVCs and to compare the pattern
of organisms from CVCs inserted in the ICU with CVCs
inserted in the operating theatre (OT) for general hospital
ward patients.
2. Methods
The study was set in a 525-bed city centre tertiary referral
institution. The TPN service is run from the ICU under the
clinical direction of the intensive care consultant staﬀ and
receives referrals from all disciplines.
All patients commenced on TPN are subject to a hospital
audit process and a monitoring database was established
in 1990. Data were entered prospectively into TPN audit
records by the dedicated TPN surveillance nurse practitioner.
All patients referred to the hospital TPN service for place-
ment of a standard CVC for administration of TPN between
January 1997 and January 2009 were included. Tunneled
CVCs, peripherally inserted central venous catheters (PICC),
peripheral intravenous cannulae, and CVCs that had been
inserted in other hospitals were excluded, as were patients
receiving home TPN. No antibiotic or otherwise impreg-
nated CVCs were in use during the study period.
A TPN audit committee, comprising the intensive care
consultant and senior registrar, TPN surveillance nurse,
and Microbiology consultant, met quarterly throughout the
study period [16]. Data regarding all complications of TPN
CVCs, including septic complications, were collected by the
TPN surveillance nurse and these records were reviewed
by the TPN audit committee. The committee assigned a
diagnostic category (noninfected, colonised, or CRBSI) to
all catheters potentially responsible for episodes of sepsis
occurring in the hospital TPN population, using CDC
compatible definitions [17].
All CVC tips from TPN patients were cultured, regard-
less of whether removal was because the CVC was no
longer required or because of suspected CVC-related sepsis.
Catheter tip culture positivity (CP) was defined as growth
of >15 colony forming units (cfu) per mL from the
inside of a distal catheter segment using semiquantitative
microbiological techniques as described by Maki et al. [18].
Culture positive CVCs were deemed to be “colonised”
when catheter tip was culture positive but not associated with
clinical sepsis [17, 19]. “CRBSI” episodes were diagnosed
in patients with culture-positive CVCs meeting the CDC
criteria for CRBSI current at the time, outlined as follow
[17].
(i) isolation of an organism by semiquantitative culture
from a catheter segment in a patient with clinical
sepsis [20], and
(ii) isolation of the same organism from the patient’s
blood, or
(iii) defervescence of sepsis following removal of the
catheter.
Care and maintenance of CVCs were standardised in
the hospital. The subclavian vein was the recommended
anatomical approach provided the operator was comfortable
with this in the individual patient, and there were no
contraindications to this approach. The CVCs were placed by
predetermined registrars in intensive care/anaesthesia under
TPN service consultant supervision. All CVCs were inserted
either in the ICU (intensive care and high dependency units)
or in the OT for TPN administration in general ward patients
(OT/ward CVCs). Patients received standardised care as
outlined previously [21]. CVCs were carefully removed by
nurses using written protocols involving initial antiseptic
cleaning, the tip being removed under aseptic conditions and
sent for culture in all situations.
Organisms isolated from CVC tips were categorised as
follows:
(1) methicillin-sensitive Staphylococcus aureus (MSSA)
(2) coagulase-negative Staphylococcus (CNS)
(3) methicillin-resistant Staphylococcus aureus (MRSA)
(4) gram-negative Bacilli (GNB)
(5) fungi
(6) enterococci
(7) polymicrobial causes.
2.1. Statistical Analysis. The data was collated from the spe-
cific TPN audit records and transferred into spreadsheets. All
CVCs that became culture positive, incorporating colonised
CVCs and those responsible for CRBSI, were examined.
Statistical analysis was by means of paired t tests, comparing
the incidence of each causative organism.
Incidence rates for CRBSI and culture positivity were also
compared using paired t tests. In order to examine whether
there were any changes in infection rates over the course
of the study period, ordinary least squares regressions were
conducted.
In each regression, the incidence rate in each group
(CRBSI, culture positive) for a particular year was the
dependent variable, with the sole independent variable being
the year. The diﬀerence in rates between the two groups was
also used as a dependent variable. These three regressions
allow us to identify whether, for each outcome (viz. the
infection rate in the CRBSI, the incidence rate in the culture-
positive group, and the diﬀerence in incidence rates between
CRBSI and culture-positive groups), whether there was any
statistical reduction or increase over time. The whole analysis
was carried out using Stata 10.
3. Results
Throughout the twelve-year study period, spanning January
1997 to January 2009, a total of 1392 patients received TPN
via 2,565 CVCs over 15,397 CVC days. 25.4% (651/2565)
of CVCs inserted for TPN administration throughout the
study period became culture positive. Of these culture
positive CVCs, 68% (441/651) were colonised and 32%
(210/651) were associated with the development of CRBSI.
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Figure 1: Annual incidence of culture-positive CVCs and CRBSI
expressed as episodes per 1000 CVC days.
Table 1: Comparison of CRBSI versus culture positive CVCs
(episodes per year).
Variable
Mean annual
number of episodes
Standard error
CVCs that developed
CRBSI
17.5 1.98
CVCs that became culture
positive
54.25 2.15
Diﬀerence −36.75 1.83
P < 0.01. Legend: The diﬀerence between CP and CRBSI episodes of
36.75 (SE 1.83) over the 12 years of observation is statistically significant,
suggesting a consistent pattern of culture positive CVCs that resulted in
development of CRBSI.
Table 2: Regression analysis using ordinary least squares (OLS)
expressing the decline in culture-positive and CRBSI rates per year
over 12 years.
Year Standard error
Culture positive −0.465 (−0.64)
CRBSI −1.182∗ (−0.47)
∗
P < 0.05.
Figure 1 depicts the annual incidence of culture-positive
CVCs subdivided into colonised CVCs and those responsible
for CRBSI expressed as episodes per 1000 CVC days.
Table 1 shows that the proportion of culture pos-
itive CVCs that were associated with CRBSI averaged
32% (derived from mean annual number of episodes =
17.5/54.25), the diﬀerence between culture positive and
CRBSI was statistically significant at −36.75 (SE 1.83), (P <
0.01).
Table 2 shows the decline in the proportion of CVCs
that became culture positive in the study period. In contrast
to the previously reported significant fall in CRBSI rate
(the regression analysis estimates a significant fall of 1.182
on average for each year in the study period, (P < 0.05)
[21]); the decline in culture-positive CVCs (0.465) was not
statistically significant (P > 0.05).
Table 3 depicts the pattern of organisms isolated from
CVCs that became culture positive and those responsible for
development of CRBSI. It demonstrates that a similar pattern
of organisms was isolated from CVC tips of both groups for
all categories of causative organisms with the exception of
enterococci, which were statistically more likely to be isolated
in culture positive than CRBSI CVC tips (P = 0.04).
Table 4 displays causative organisms isolated from cuture
positive CVCs in ICU and OT/ward CVCs, and shows
that the proportion of culture positive CVCs that grew
staphylococci (incorporating MSSA, CNS and MRSA) was
significantly higher in OT/ward CVCs (74.7%) compared to
ICU (64%), (P = 0.01). More specifically, MSSA isolation
was significantly higher in the OT/ward CVCs compared
to ICU (P < 0.01). There were no other significant
diﬀerences in the pattern of organism isolated between ICU
and OT/ward CVCs.
4. Discussion
In this large study of hospital-wide TPN patients, we examine
the prevalence of CVC tip culture positivity, incorporating
both those CVCs that became culture positive in the absence
of systemic sepsis (colonised CVCs) and culture-positive
CVCs causative of systemic infection (CRBSI CVCs), in a
hospital-wide TPN service. We do not recommend that
routine culture of CVC tips be carried out, however, given
that the policy and practice was to culture all CVC tips used
for TPN administration throughout the study period in such
a large, hospital-wide TPN population, we were aﬀorded the
unique opportunity to carry out the current analysis allowing
us to fully define the relationship between culture positive
CVC tips and subsequent development of CRBSI using
standard CDC diagnostic criterion. Our results demonstrate
that 25% of standard, nontunnelled CVCs inserted for TPN
administration became culture positive throughout the study
period, and that there was a consistent relationship between
culture positivity and the development of CRBSI (Table 1).
The terminology utilized in much of the literature to
describe colonised and infected CVCs is inconsistent as many
studies appear to use the word “colonised” to include all
catheters that are tip positive (by local/standard criteria)
[1, 2, 6, 22–24]. However, these studies then describe
the proportion of these “colonised” CVCs that resulted
in systemic infection (CRBSI) thus creating an inherent
contradiction as CVCs responsible for CRBSI episodes are
thus being included in the “colonised” group. We concur
with the clarifying terminology utilized in a recent study
examining CRBSI/colonisation in arterial cannulae which
utilises the term “culture positive” to cover both categories
(colonised CVCs and those CVCs that resulted in CRBSI)
[25], as it is descriptively precise and we have used this
terminology here.
In a review by Marik [1], it is suggested that approx-
imately 25% of CVCs becomes colonised. However, this
estimate was based on evidence using varying terminology,
from a variety of clinical settings including arterial catheters,
CVCs, and antibiotic-impregnated CVC studies [25–27]
4 Journal of Nutrition and Metabolism
Table 3: Pattern of organisms isolated in culture-positive and CRBSI CVCs.
Causative organisms
Culture-positive CVCs
Mean % annual incidence ± Std Dev
CRBSI CVCs
Mean % annual incidence ± Std Dev P value
All staphylococci (CNS, MSSA, MRSA) 69.2± 8.0 69.7± 16.22 0.9
CNS 59.2± 4.5 57.5± 11.4 0.6
MSSA 1.7± 1.3 1.0± 1.9 0.3
MRSA 8.3± 6.8 11.1± 11.6 0.5
Gram-negative Bacilli 11. 8± 6.3 12.2± 8.9 0.9
Fungi 5.7± 2.8 6.1± 4 0.8
Enterococci 2.4± 1.7 0.8± 1.9 0.04
Polymicrobial 10.8± 4.9 11.2± 8.5 0.9
and there was considerable variability in colonisation and
infection rates. The current study, of a large population of
uniform, nontunneled, standard, nonantibiotic impregnated
CVCs, confirms a culture positive, not colonization, rate of
25.4% for all CVCs.
There is limited published evidence to support the rela-
tionship between culture-positive CVCs and the subsequent
development of CRBSI. In the review mentioned above,
Marik has suggested that between 20–30% of “colonised”
catheters results in CRBSI [1]. In a large meta analysis
Rijnders et al. [28], the authors demonstrate a linear
correlation between catheter tip “colonisation” and CRBSI.
This correlates with the evidence of the current study where
32% of TPN CVCs that became culture positive resulted
in the development of CRBSI, a relationship that was
consistent throughout the study period (Table 1). This study
provides further circumstantial evidential support for CVC
tip colonisation as an important pathogenic mechanism for
CRBSI in that it demonstrates a similar pattern of organism
growth from both colonised and CRBSI CVCs (Table 3).
The decline in CVC culture positive rates seen (Table 2,
an estimated reduction of 0.465 on average per year during
the study period, P > 0.05) did not reach statistical
significance in this study but is likely related to the known
significant decline in CRBSI rate in this population (Table 2,
an estimated reduction of 1.182 on average per year during
the study period, P < 0.05) and reflective of the value
of a surveillance nurse implementing hygiene and other
preventative measures as a probable means of reducing
CRBSI [21]. This decline in CRBSI correlates with data
presented in the literature describing falling CRBSI rates,
resulting in overall CRBSI incidences tending to be generally
low, in the region of 5 episodes per 1000 CVC days [29].
With such a low prevalence of CRBSI, it is diﬃcult to
detect diﬀerences in outcome measures such that extremely
large numbers of patients and CVCs would need to be
recruited in future studies to demonstrate significant dif-
ferences between groups, and others have alluded to this
diﬃculty [28]. This has led to the suggestion of use of CVC
tip colonisation as a representation, or surrogate marker,
for CRBSI in many clinical studies [30–34]. This use of
colonisation data for CVC tips has been demonstrated to be
a practicable endpoint in future studies by Rijnders et al.
in a large review of the current evidence [28]. Given that
the current study provides further evidential support for
the relationship between culture positivity and CRBSI and
presuming the consistency of this relationship is confirmed
in further studies, it supports the auditing of CVC tip culture
positivity as a surrogate surveillancemarker for CRBSI which
may provide a more dynamic measurement of trends than
CRBSI measurement alone—especially where numbers of
CVCs inserted are low. However, this would entail culturing
all removed CVCs, regardless of whether or not catheter-
related infection was suspected, and the issue of cost versus
benefit would require analysis in any hospital/laboratory
considering such a regular process.
It has been proposed that TPN, being a potential culture
medium, is an independent risk factor for CRBSI [35–
38]. However, there is a paucity of studies related to CVC
colonisation and CRBSI and in patients receiving TPN
via short-term CVCs. Of the limited prospective studies
of CRBSI among TPN patients, levels reported are diverse
with CRBSI rates ranging from 55.2% in one study [39]
and 11.46% in another [37]. Insofar as one can judge the
current evidence base, the proportion of culture-positive
CVCs that resulted in CRBSI was little diﬀerent from those
quoted for CVCs for general use. Suggestions that TPN is
an independent risk factor for CRBSI (and perhaps culture
positivity) are therefore questioned by data from this study.
In a CDC survey published in 2003, 55% of patients
in the ICU had a CVC in situ, compared with 24% of
ward patients [11]. However, because of the much larger
population of patients located on general hospital wards, the
majority of CVCs in use were in fact inserted in patients
who were located outside of the ICU (70%) [11], and
this is probably the case for most institutions. This has
implications for the care and use of CVCs. One study
reports higher risks of breaches in CVC care to occur on
wards [40]. In another study, non-ICU patients tended to
have CVCs in situ for longer periods of time [41]. Both
of these are factors that place patients at higher risk of
CRBSI and focus is now turning toward the measurement
of CRBSI incidence and epidemiology in CVCs inserted in
patients at ward level [12]. Despite this, there are very limited
studies examining CVC colonisation and CRBSI among non-
ICU populations, and less is still that compare these in a
homogenous population. The current study is unique in that
it provides comprehensive data on the microbiology of CVC
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Table 4: Culture-positive CVCs by category of isolated organism comparison of critical care and ward areas.
Causative organisms
ICU
Mean % annual incidence ± Std Dev
OT/ward areas
Mean % annual incidence ± Std Dev P value
All staphylococci (CNS,
MSSA, MRSA)
64± 10.3 74.7± 7.2 0.01
CNS 55.9± 7.9 62.4± 8.4 0.10
MSSA 0.3± 1 4.6± 2.1 <0.01
MRSA 7.9± 8.8 8.6± 6.7 0.80
Gram-negative Bacilli 14.6± 9.3 9± 4.8 0.10
Fungi 5.9± 3.8 5.6± 4.4 0.80
Enterococci 3.4± 3.1 1.5± 1.9 0.10
Polymicrobial 12.1± 4.6 9.2± 5.7 0.20
tip colonisation and CRBSI in CVCs inserted in patients both
in the ICU and at ward level.
In a recent study by Zingg et al. [42], similar rates of
CRBSI were determined among ICU and non-ICU patients,
with most CRBSI being due to gram-positive organisms
(60%), followed by gram-negative organisms (13%). How-
ever, they do not separate out causative organisms in ICU
and non-ICU CVCs. In fact, we could find no studies com-
paring causative organisms for colonised or CRBSI CVCs
in ICU and non-ICU patients within the same institution.
Causative organisms for CRBSI among ICU patients tend to
most commonly be due to gram-positive organisms between
55.4–88%, followed by gram-negative organisms 8.5–30.1%
and candida 2.8–11.7% [10, 43–45]. Other studies examining
CRBSI in non-ICU populations determined gram-positive
organisms to be the most common causative organisms
responsible for between 40–57% of CRBSI episodes [13,
46, 47]. Gram-negative organisms were causative for 17%
of CRBSI in these studies of non-ICU patients followed by
candida in 12–14% [13, 46].
These data correlate with the results of the current study,
with gram-positive organisms being the most common
causative organism in both culture-positive and CRBSI CVCs
(Table 4) in both the ICU and at ward level, followed by
gram-negative organisms with a trend (although nonsignif-
icant) toward increased incidence among ICU CVCs. The
use of vancomycin as empiric antibiotic therapy to treat
suspected CRBSI is further supported by the current study.
However, Table 4 shows that this consideration appears to be
even more appropriate in OT/ward CVCs where there was
a significantly higher (P < 0.01) staphylococcal isolation
rate (74% of CVCs) than in ICU (64%) and the rate of
MSSA isolation specifically was also significantly higher (P <
0.01) in OT/ward patients (4.6%) than in ICU (0.3%). This
may reflect the slightly (but not significantly) higher GNB,
enterococcal, and polymicrobial isolates from ICU CVCs.
Strengths of this study include its large size, the system-
atic tracking of prospectively collected data on 1392 patients
over 15,397 CVC days in patients receiving TPN, and the use
of the same diagnostic microbiological criteria (for catheter
tip positivity) and the same multidisciplinary process using
CDC criteria for CRBSI diagnosis over the 13 years of
the study. Weaknesses are the observational nature of the
study design, the questionable relevance of CVC colonisation
as a clinical entity, and the possibility of CVC culture
positivity being merely representative of contamination at
the time of CVC removal. However, the standard procedure
for CVC removal outlined in the methods and the TPN
surveillance nurse may have provided protection against this.
Furthermore, although the CVC tip culture methodology
used has been arguably superseded, its 13 years of consistent
use lent validity to this study.
In conclusion, this large study of TPN CVCs demon-
strates a consistent relationship between CVC culture pos-
itivity and CRBSI, and that the organism pattern for
culture-positivity and CRBSI is similar thus supporting the
contention that colonisation is related to CRBSI and that
CVC culture positivity may be a useful surrogate marker for
CRBSI rates [26]. Staphylococci are the primary organism
causing culture positivity in all CVCs and are significantly
more likely to be cultured in OT/ward patients than ICU
patients. This study also highlights, that as 25% of CVCs
became culture positive and 32% of these were responsible
for development of CRBSI, continued vigilance to reduce
infection through prevention methods remains important.
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